Childhood ADHD Tied to Higher Risk of Physical Health Problems by Midlife - Inside Precision Medicine
Google News • 1/21/2026 – 1/23/2026
Summary
Childhood ADHD is linked to a higher risk of physical health problems by midlife. This connection suggests that ADHD may affect lifelong health, as reported by multiple sources including Inside Precision Medicine, SciTechDaily, Medical Xpress, The Week, and The Independent.
Advertisement
Lindy Score Breakdown (V4.2)
72d
Age
1
Sources
from cluster
1694
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1694/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1694/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 72 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Insilico Medicine CEO on how best to use AI in drug development
Stat News • 2 days ago
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 1 day ago
STAT+: How health care could gum up Trump’s reconciliation push
Stat News • 1 day ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • Today
Supreme Court conversion therapy decision could ripple through medicine
Stat News • 1 day ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 2 days ago
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Stat News • 2 days ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago